Company Filing History:
Years Active: 2009
Title: Mi He - Innovator in Chromatin Peptide Drug Development
Introduction
Mi He is a notable inventor based in Wuxue, China. She has made significant contributions to the field of biotechnology, particularly in the development of chromatin peptide drug molecules. Her innovative work focuses on addressing critical health issues related to tumor proliferation and chronic inflammation.
Latest Patents
Mi He holds a patent for "Chromatin peptides blocking human HIF-1α gene and modulating the downstream related genes." This patent describes chromatin peptide drug molecules that can effectively block the human cell hypoxia responsive pathway. These molecules are designed to bind specifically to the HIF-1α gene self-promoter or its downstream regulated gene promoters, which include more than 40 genes. The technology aims to permanently shut down molecular pathways involved in cell glycolysis, immuno-inflammation, and hypoxia response. This innovative approach has the potential to halt the uncontrollable proliferation of late-stage tumor cells or chronic inflammation cells under hypoxic conditions. Mi He has 1 patent to her name.
Career Highlights
Throughout her career, Mi He has demonstrated a strong commitment to advancing medical science through her research and inventions. Her work has garnered attention for its potential to revolutionize treatments for various diseases, particularly those related to cancer and inflammation.
Collaborations
Mi He collaborates with esteemed colleagues, including Xiaozhuang Bian and Chengqiu Wang, who contribute to her research endeavors. Their combined expertise enhances the development and application of her innovative technologies.
Conclusion
Mi He is a pioneering inventor whose work in chromatin peptide drug development holds promise for significant advancements in medical treatments. Her contributions to biotechnology are noteworthy and reflect her dedication to improving health outcomes.